David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 26,811 shares at $0.71 ($18K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Open-market purchase of $18k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 2,720 | $2K | 10.5% |
| 2 | $0.71 | 16,791 | $12K | 64.9% |
| 3 | $0.62 | 1,460 | $905 | 4.9% |
| 4 | $0.62 | 5,840 | $4K | 19.7% |
| Total | $0.69 avg | 26,811 | $18K | 100% |
| Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |
| NGM | BUY | 2023-02-01 | $921K | — | Filing → |